The use of levo-carnitine in children with renal disease

A review and a call for future studies

Brook Belay, Nora Esteban-Cruciani, Christine A. Walsh, Frederick J. Kaskel

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Carnitine is an amino acid derivative that has a key role in the regulation of fatty acid metabolism and ATP formation. Carnitine deficiency has been described in various conditions, including chronic kidney disease (CKD) and end stage renal disease (ESRD). The deficiency of this micronutrient is postulated to lead to adverse effects across multiple organ systems. There is a paucity of information on carnitine deficiency and its effects in the pediatric CKD and ESRD populations. Currently, there is no evidence supporting the routine use of carnitine supplementation in children with ESRD. In this article, we review the pathophysiology, pharmacokinetics and the potential effects of levo-carnitine supplementation with a focus on the pediatric CKD and ESRD populations. Finally, potential future directions of research are discussed.

Original languageEnglish (US)
Pages (from-to)308-317
Number of pages10
JournalPediatric Nephrology
Volume21
Issue number3
DOIs
StatePublished - Mar 2006

Fingerprint

Carnitine
Chronic Kidney Failure
Kidney
Chronic Renal Insufficiency
Pediatrics
Micronutrients
Population
Fatty Acids
Pharmacokinetics
Adenosine Triphosphate
Amino Acids
Research

Keywords

  • Anemia
  • Cardiac disease
  • Carnitine deficiency
  • Children
  • Kidney disease

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

The use of levo-carnitine in children with renal disease : A review and a call for future studies. / Belay, Brook; Esteban-Cruciani, Nora; Walsh, Christine A.; Kaskel, Frederick J.

In: Pediatric Nephrology, Vol. 21, No. 3, 03.2006, p. 308-317.

Research output: Contribution to journalArticle

Belay, Brook ; Esteban-Cruciani, Nora ; Walsh, Christine A. ; Kaskel, Frederick J. / The use of levo-carnitine in children with renal disease : A review and a call for future studies. In: Pediatric Nephrology. 2006 ; Vol. 21, No. 3. pp. 308-317.
@article{c141879e6d6b4ad180f15c28956c68f9,
title = "The use of levo-carnitine in children with renal disease: A review and a call for future studies",
abstract = "Carnitine is an amino acid derivative that has a key role in the regulation of fatty acid metabolism and ATP formation. Carnitine deficiency has been described in various conditions, including chronic kidney disease (CKD) and end stage renal disease (ESRD). The deficiency of this micronutrient is postulated to lead to adverse effects across multiple organ systems. There is a paucity of information on carnitine deficiency and its effects in the pediatric CKD and ESRD populations. Currently, there is no evidence supporting the routine use of carnitine supplementation in children with ESRD. In this article, we review the pathophysiology, pharmacokinetics and the potential effects of levo-carnitine supplementation with a focus on the pediatric CKD and ESRD populations. Finally, potential future directions of research are discussed.",
keywords = "Anemia, Cardiac disease, Carnitine deficiency, Children, Kidney disease",
author = "Brook Belay and Nora Esteban-Cruciani and Walsh, {Christine A.} and Kaskel, {Frederick J.}",
year = "2006",
month = "3",
doi = "10.1007/s00467-005-2085-4",
language = "English (US)",
volume = "21",
pages = "308--317",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - The use of levo-carnitine in children with renal disease

T2 - A review and a call for future studies

AU - Belay, Brook

AU - Esteban-Cruciani, Nora

AU - Walsh, Christine A.

AU - Kaskel, Frederick J.

PY - 2006/3

Y1 - 2006/3

N2 - Carnitine is an amino acid derivative that has a key role in the regulation of fatty acid metabolism and ATP formation. Carnitine deficiency has been described in various conditions, including chronic kidney disease (CKD) and end stage renal disease (ESRD). The deficiency of this micronutrient is postulated to lead to adverse effects across multiple organ systems. There is a paucity of information on carnitine deficiency and its effects in the pediatric CKD and ESRD populations. Currently, there is no evidence supporting the routine use of carnitine supplementation in children with ESRD. In this article, we review the pathophysiology, pharmacokinetics and the potential effects of levo-carnitine supplementation with a focus on the pediatric CKD and ESRD populations. Finally, potential future directions of research are discussed.

AB - Carnitine is an amino acid derivative that has a key role in the regulation of fatty acid metabolism and ATP formation. Carnitine deficiency has been described in various conditions, including chronic kidney disease (CKD) and end stage renal disease (ESRD). The deficiency of this micronutrient is postulated to lead to adverse effects across multiple organ systems. There is a paucity of information on carnitine deficiency and its effects in the pediatric CKD and ESRD populations. Currently, there is no evidence supporting the routine use of carnitine supplementation in children with ESRD. In this article, we review the pathophysiology, pharmacokinetics and the potential effects of levo-carnitine supplementation with a focus on the pediatric CKD and ESRD populations. Finally, potential future directions of research are discussed.

KW - Anemia

KW - Cardiac disease

KW - Carnitine deficiency

KW - Children

KW - Kidney disease

UR - http://www.scopus.com/inward/record.url?scp=33244487237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244487237&partnerID=8YFLogxK

U2 - 10.1007/s00467-005-2085-4

DO - 10.1007/s00467-005-2085-4

M3 - Article

VL - 21

SP - 308

EP - 317

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 3

ER -